University-CA Berkeley

The laboratory at University-CA Berkeley in Albany, CA is dedicated to advancing the understanding of cytotoxic cells, particularly natural killer (NK) and cytotoxic T cells, in their role of identifying and eliminating cancerous and infected cells. Through innovative research, the team explores mechanisms of activation and inhibition of these cells to enhance existing immunotherapies and develop new treatment combinations for resistant cancers.

In collaboration with various research centers and an accomplished team of scientists, the lab has made significant strides in immunotherapy, notably through studies on STING agonists and superkines. Their efforts include a focus on understanding NK cell dynamics and gene expression, leading to promising findings that may reshape immunotherapeutic strategies in cancer treatment.

Generated from the website